Kymera Therapeutics, Inc.
Clinical trials sponsored by Kymera Therapeutics, Inc., explained in plain language.
-
New pill could ease severe eczema for teens and adults
Disease control Recruiting nowThis study tests an oral medication called KT-621 for people aged 12 to 75 with moderate to severe atopic dermatitis (eczema). The goal is to see if it reduces skin redness, itching, and affected body area. About 200 participants will receive either the drug or a placebo for 16 w…
Phase: PHASE2 • Sponsor: Kymera Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New daily pill aims to tame severe eosinophilic asthma
Disease control Recruiting nowThis study tests an oral medication called KT-621 in adults with moderate to severe eosinophilic asthma that is not well controlled by current treatments. The goal is to see if the drug improves lung function and asthma control, and to check its safety. About 264 participants wil…
Phase: PHASE2 • Sponsor: Kymera Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Healthy volunteers needed for first human test of experimental drug KT-579
Knowledge-focused Recruiting nowThis early-stage study is the first time the drug KT-579 is being tested in humans. It aims to check the drug's safety and how the body processes it in 96 healthy adults. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and mea…
Phase: PHASE1 • Sponsor: Kymera Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC